TissueForm, Inc.
PrivateLast Round
Grant
May 18, 2023
Est. Valuation
$9.75M
Total Funding Raised
$2.37M
Company Overview
TissueForm, Inc. operates in Healthcare & Life Sciences and is based in Boulder, Colorado. Its latest recorded funding round was a Grant round in May 2023.
TissueForm, Inc. is a biomedical technology company that develops natural implants to restore lost tissue structure.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials, 3D Printing
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TissueForm, Inc. Comparables
Compare TissueForm, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ECM Therapeutics, Inc. | 81% | |
| Regenative Labs | 78% | |
| MTF Biologics | 75% |
For institutional investors. Book with your work email.
TissueForm, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 18, 2023 | ||||
| Seed | Jan 1, 2023 | ||||
| Grant | Mar 23, 2021 | ||||
| Grant | Mar 22, 2019 | ||||
| Grant | Nov 20, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
TissueForm, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| Venture Partners at CU Boulder | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2023
Secured $250K in grant funding.
- Jan 1, 2023
$750K round completed.
For institutional investors. Book with your work email.
TissueForm, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TissueForm, Inc.'s valuation, stock price, and market status.
Is TissueForm, Inc. a public or private company?
TissueForm, Inc. is a private company.
What is the current stock price of TissueForm, Inc.?
TissueForm, Inc. is a private company, so its shares have no public market price. Caplight tracks TissueForm, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TissueForm, Inc. worth (valuation)?
TissueForm, Inc.'s valuation is estimated at $9.8M based on funding round data.
Can I buy TissueForm, Inc. stock?
TissueForm, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TissueForm, Inc.'s last funding round?
TissueForm, Inc.'s most recent funding round was Grant on May 18, 2023.
Who are the main investors in TissueForm, Inc.?
Key investors in TissueForm, Inc. include United States Department of Defense, Venture Partners at CU Boulder.
Will TissueForm, Inc. IPO soon?
No public IPO plans have been announced for TissueForm, Inc..
How can I track TissueForm, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in TissueForm, Inc.'s shares on secondary markets.